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A B S T R A C T   
Introduction: A recent study showed hypoactivity in the beta/gamma band in female suicide ideators and suicide 
attempters diagnosed with depression, relative to a low-risk group. The current study aimed to conceptually 
replicate these results. 
Methods: In the iSPOT-D sub-sample (n = 402), suicide ideators and low-risk individuals were identified. 
Confining analyses to females only, differences between low-risk individuals and suicide ideators were tested for 
using the electroencephalogram (EEG) frequency bands SMR (Sensori-Motor-Rhythm; 12− 15 Hz), beta (14.5− 30 
Hz), beta I (14.5− 20 Hz), beta II (20− 25 Hz), beta III (25− 30 Hz), gamma I (31− 49 Hz) using LORETA-software. 
Results: None of the tested frequency bands showed to be significantly different between suicide ideators and low- 
risk individuals. 
Conclusions: The current study could not conceptually replicate the earlier published results. Several reasons 
could explain this non-replication, among which possible electromyographic (EMG) contamination in the beta/ 
gamma band in the original study. 
Trial Registration: ClinicalTrials.gov identifier: NCT00693849. 
URL: http://clinicaltrials.gov/ct2/show/NCT00693849.   
1. Introduction 
Recently, a study examining the resting state EEG signature of 
depressed individuals at multiple levels of suicide risks was published by 
several of us (Benschop et al., 2019). Benschop and colleagues, limiting 
the analysis to females only, demonstrated that suicide ideators and 
suicide attempters showed low frontal beta and gamma activation as 
compared to low-risk individuals, with quite similar topography for both 
ideator and attempter groups. Furthermore, higher occipital alpha was 
observed in ideators. Interestingly, research into the electroencephalo-
gram (EEG) correlates of suicidal behavior is scarce. A recent report by 
Arikan and colleagues showed that suicide ideators exhibited higher 
gamma (Arikan, Gunver, Tarhan, & Metin, 2019), contrasting the results 
by Benschop and colleagues. It has also been found that lower gamma 
power was related to an increased response to paroxetine treatment in 
depression (Arikan, Metin, & Tarhan, 2018), whereas Whitton et al. 
(2018) found higher 18.5− 21 Hz activity within the default mode 
network as well as higher 12− 18 Hz connectivity between the default 
mode network and the frontoparietal network in individuals with 
depression, as compared to individuals who remitted from depression. 
Additionally, higher between-network connectivity was related to more 
frequent depressive episodes since the first depression onset (Whitton 
et al., 2018). Lee, Jang, & Chae (2017) found that individuals exhibiting 
suicidal ideation showed higher frontal theta power. Another study, 
albeit confined to polysomnography, showed higher alpha and beta 
(albeit the result for beta was trend level significant) power in in-
dividuals experiencing higher levels of suicidal ideation (Dolsen et al., 
2017). All in all, the EEG correlates of suicidal ideation and behavior are 
still unclear. Given the clinical relevance of early and accurate identi-
fication of individuals experiencing symptoms of suicidal ideation or 
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behavior, more research is needed in this area. 
The aim of the current study was to partially replicate the findings by 
Benschop et al. (2019), using data from the randomized, controlled, 
multicenter iSPOT-D study in 1008 MDD subjects (for additional infor-
mation on this study and its parameters, please see: (Arns et al., 2016; 
Saveanu et al., 2015; Williams et al., 2011)). Since ‘attempted suicide in 
the last 30 days’ was an exclusion criterion for the iSPOT-D study 
(Williams et al., 2011), and thus no attempter group could be formed, 
the a priori defined hypothesis was that in female suicide ideators, 
relative to the low-risk group, beta/low gamma hypoactivation would 
be observed in the pre-frontal regions. 
2. Methods and materials 
The iSPOT-D study (registered at ClinicalTrials.gov (identifier: 
NCT00693849)) included 1008 patients diagnosed with Major Depres-
sive Disorder (MDD). For the purpose of this study and replication, only 
the suicide items administered using the Mini-International Neuropsy-
chiatric Interview (MINI-plus) were considered and only females were 
included (in line with Benschop et al. (2019)). Also, individuals 
reporting to have attempted to commit suicide in a lifetime but not in the 
last 30 days, and who also did not report any suicidal ideation, were 
excluded. This was done to solely focus on acute suicide risk and is in 
line with Benschop et al. (2019). 
3. Statistics 
In the current study, the EEG frequency bands as reported by Ben-
schop et al. (2019) were prospectively tested in LORETA. 
3.1. LORETA analyses  
1) Analyses were performed using LORETA v20200106 in Windows 10, 
standalone version. LORETA tests statistical group differences based 
on nonparametric permutation tests for functional neuroimaging. 
The original bands that were found to be significantly different be-
tween low-risk individuals and ideators were SMR (12− 15 Hz), beta 
(14.5− 30 Hz), beta I (14.5− 20 Hz), beta II (20− 25 Hz), beta III 
(25− 30 Hz), and gamma I (31− 49 Hz) (Benschop et al., 2019). Thus, 
in the current study, these identical bands were investigated. Using 
LORETA, differences between suicide ideators and low-risk in-
dividuals in the iSPOT-D sample were examined. Significance level 
was set at p < 0.01, in line with other iSPOT-D studies (e.g., Arns 
et al. (2016)). Note: the original study also reports alpha hyperac-
tivity in the occipital regions in suicide ideators. However, this 
finding was not found using LORETA software. To enhance compa-
rability with the original study, it was decided to primarily focus on 
14.5− 48 Hz in the ROI analyses. In the first results Section (3.1) 
alpha (9− 13 Hz, in line with Benschop et al. (2019)) will only be 
shortly elaborated on. 
2) After this initial replication, a second exploratory analysis was per-
formed. Based on the results presented in Benschop et al. (2019), a 
single target frequency band of 14.5− 48 Hz was established (con-
sisting of the frequencies showing most prominent differences be-
tween suicide ideators and low-risk individuals). Then, using this 
frequency band (‘suicide-specific band’) a Region of Interest (ROI) 
was created in LORETA. Note that this ROI was created based on 
voxels being significantly different between low-risk individuals and 
ideators in the original study. Thus, this is not a pre-existing ROI. 
This ROI was used to extract beta/low gamma current source density 
(CSD) for all patients, after which statistical differences between 
high-risk and low-risk individuals were examined. In SPSS 26 for 
Mac, a GLM Univariate using beta/low gamma activation as a 
dependent variable, suicide group as a between-subject variable, and 
age as a covariate was performed. This analysis was performed for 
both the original data as well as the iSPOT-D sample, in order to 
compare results and consistency between the samples. The p-value 
was set on 0.05 and 0.01 for the original and iSPOT-D sample, 
respectively, given the larger sample size and exploratory nature in 
iSPOT-D. This is in line with other iSPOT-D reports that employed a 
0.01 threshold (e.g., Arns et al. (2016)). 
4. Results 
Excluding individuals with no acute suicide risk (consisting of in-
dividuals with past suicide attempts, but no current suicidal ideation), 
females with missing data, and males, the resulting sample size was n =
402. This sample consisted of 188 suicide ideators (age range (in years): 
18–65, m = 37.2, SD = 13.3) and 214 low-risk individuals (age range (in 
years): 19–85, m = 37.7, SD = 12.5).  
1) No significant differences were found between low-risk individuals 
and ideators for SMR (p = .383), beta (p = .291), beta I (p = .339), 
beta II (p = .344), beta III (p = .201), and gamma I (p = .255), 
thereby failing to replicate the earlier result as reported by Benschop 
et al. (2019). Alpha also did not show to be significantly different 
between ideators and low-risk individuals (p = .143). 
4.1. ROI analyses  
2) A ROI was developed based on the original sample (nlow-risk = 23 
(29.5 %), nideators = 36 (46.2 %), nattempters = 19 (24.4 %)) as used by 
Benschop et al. (2019), using the 14.5− 48 Hz frequency range, 
consisting of the voxels showing to be significantly different between 
low-risk individuals and ideators at p < .01, one-tailed. In the orig-
inal sample, a GLM Univariate analysis showed a significant main 
effect of suicide group (F(2,74)=3.505, p = .035). Significant dif-
ferences were observed when contrasting ideators with low-risk in-
dividuals (F(1,56)=5.904, p = .018; d=-.61), but not when 
contrasting attempters with ideators (F(1,52) = 2.079, p = .155; d =
.28), nor for attempters and low-risk individuals (F(1,39) = 1.326, p 
= .257; d=-.44), also see Fig. 1 below. Importantly, the direction of 
the results comparing low-risk to ideators and low-risk to attempters 
is identical (specifically, ideators and attempters show decreased 
activity compared to low-risk individuals) and the effect sizes are 
medium to large. This confirms that the established ROI and fre-
quency band reflects the results as originally reported. 
Fig. 1. This violin plot displays the CSD extracted from the ROI (14.5–48 Hz), 
separated by suicide group and sample group. The ROI is based on the original 
sample. Note that the ‘Low-risk original sample’ seems to have the largest 
spread. CSD = current source density. 
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Repeating this analysis on iSPOT-D, a GLM univariate showed a non- 
significant and opposite effect between ideators and low-risk individuals 
(F(1,399) = 6.153, p = .014; d = .25). This effect can be observed in 
Fig. 1. 
5. Discussion 
The current study aimed to partially replicate the results as reported 
by Benschop et al. (2019), which demonstrated a beta/gamma hypo-
activation in female suicide ideators and attempters, as compared to 
low-risk individuals. Unfortunately, the current results did not confirm 
the results of the original study, meaning that no difference in the 
beta/low gamma band was found between suicide ideators and low-risk 
individuals. The current results were more in line with a recent report by 
Arikan et al. (2019), in which high gamma power at electrodes F4, Fz, 
C4, Cz, O2, F8, T5, and T6 was observed in individuals reporting higher 
levels of suicidal ideation. Another possibility is that gamma is not 
specifically related to suicidal ideation, but to a more general presen-
tation of symptoms of depression. A recent report by Fitzgerald & 
Watson (2018) suggested that various gamma activity patterns in 
different brain areas may be related to depression. It also was suggested 
that gamma may even be able to discriminate between bipolar and 
unipolar depression (Fitzgerald & Watson, 2018). Additionally, 
although suicidal ideation and depression are heavily intertwined, sui-
cidal ideation is not a symptom solely present in depression. For 
example, suicidal ideation has been reported in Obsessive-Compulsive 
Disorder (Pellegrini et al., 2020), Post-traumatic Stress Disorder (Kry-
sinska & Lester, 2010), schizophrenia (Chapman et al., 2015), and 
Attention-Deficit/Hyperactivity Disorder (Furczyk & Thome, 2014; 
Taylor, Boden, & Rucklidge, 2014). Future studies should explore EEG 
signatures of suicidal ideation across different disorders to investigate if 
an EEG correlate is specific to a particular disorder, or whether this 
relation behaves transdiagnostically and is apparent in multiple 
disorders. 
It is unclear why the current study did not confirm the earlier ob-
tained results. One reason could be a lack of high-risk individuals (i.e., 
‘suicide attempters’), since this was an exclusion criterion for iSPOT-D, 
thereby decreasing the signaling contrast between groups. Another 
reason could be medication effects. In the original study, the original 
sample was not tapered of medication at the time of baseline QEEG 
assessment, whereas subjects in iSPOT-D were off medication at base-
line. It has been reported that barbiturates and benzodiazepines 
augment beta activity, specifically in the 15− 25 Hz range (Blume, 
2006), yet medication effects on gamma have not been widely studied. 
Some animal studies also report NMDAR antagonist-induced gamma 
oscillations (Hiyoshi, Kambe, Karasawa, & Chaki, 2014; Jones et al., 
2012; Phillips et al., 2012), but NMDAR antagonists (ketamine, among 
others) have not been reported in the original sample. A third reason for 
the current non-replication may be sample size. The original sample 
consisted of 78 females and dividing that group into three subgroups 
Fig. 2. Snapshot of the first ten seconds of the EC EEG for the eight people scoring highest on the ROI analyses, for the original sample only, ranked from scoring 
highest to lowest. Subject 1 scored highest and subject 8 scored lowest on the ROI analyses. Note that the four highest-scoring individuals all were part of the low- 
risk group. 
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resulted in relatively small samples of the subgroups. It is possible that 
individual contributions of the EEG within relatively small sample sizes 
introduced some noise which may have altered the signal-to-noise ratio 
in the samples. As can be observed in Fig. 1, it appears that the low-risk 
TMS sample has the widest spread (CSD for low-risk individuals: 
min=− 1.01; max = 3.39; mean = .51, SD = 1.19), even relative to the 
large iSPOT-D groups (CSD for low-risk individuals: min=− 1.75; max =
2.06; mean=− .21, SD = .69; CSD for ideators: min=− 1.40; max = 2.35; 
mean=− 0.04, SD = .72). All EEG data were collected using identical 
procedures, amplifiers, and automated artifact processing (also see Arns 
et al., 2016 for full details), reducing the likelihood that the current 
non-replication can be explained by differences in hardware or signal 
pre-processing. Post-hoc visual inspection of individuals from the 
low-risk group with 14.5− 48 Hz CSD > 2.0 showed intermediate levels 
of frontal muscle tension (visualized in Fig. 2). Possibly, EMG contam-
inated the gamma activity (Whitham et al., 2007), yielding a quite 
strong signal in a relatively small sample (specifically, in the low-risk 
group), thus explaining the lower ‘gamma’ in the risk groups. In the 
original study, muscle artifacts were controlled for using a 
pre-processing pipeline and additional machine learning ICA artifact 
detection (MARA), thus the possible influences of muscle artifacts on the 
dataset would be expected to be minimal to none. Yet, individual con-
tributions to the signal possibly may have skewed the results. 
Concluding, in the current study, no consistent differences between fe-
male suicide ideators and females with low suicide risk could be found in 
the EEG beta and gamma bands. 
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